Chang Jung Min, Koo Hye Ryoung, Moon Woo Kyung
Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Radiology, Hanyang University, College of Medicine, Seoul, Republic of Korea.
Acta Radiol. 2015 Jun;56(6):652-8. doi: 10.1177/0284185114538252. Epub 2014 Jun 20.
Ultrasound (US) screening is not currently recommended as a routine screening modality in the general population of average risk. The cancer detection yield and positive predictive value in an average risk general population who undergo breast screening by experienced radiologists is unclear.
To determine the performance of screening breast US in women at an average risk for breast cancer undergoing breast screening by experienced radiologists.
This study received institutional review board approval, and informed consent was waived. A retrospective review of our database revealed 1526 women who underwent prevalence screening US at a single health screening center and had negative findings on digital mammography (MG). The Breast Imaging and Reporting Data System (BI-RADS) final assessments of the breast US were analyzed retrospectively, with the reference standard defined as a combination of pathology and a 12-month follow-up. The cancer detection rate and positive predictive value (PPV2) of the biopsies were calculated according to breast density.
The average time to perform a screening US examination was 15-20 min. Of 1526 women, 1095 (71.8%) were classified as BI-RADS category 1 or 2; 340 (22.3%) were classified as category 3; and 91 (6.0%) were classified as category 4. Five malignant lesions were found in women with dense breasts. The overall cancer detection rate was 3.3, and the cancer detection rate for dense breasts was 5.1 per 1000 screens (4.1 per 1000 screens [heterogeneously dense breast], 7.7 per 1000 screens [extremely dense breast]). The PPV2 for biopsies was 5.3%.
The radiologist-performed screening US offered to women with an average risk and dense breasts can detect additional mammographically occult breast cancers. In screening US, a relatively high rate of BI-RADS category 3 and 4 lesions was observed.
目前不建议将超声(US)筛查作为一般平均风险人群的常规筛查方式。在由经验丰富的放射科医生进行乳腺筛查的一般平均风险人群中,癌症检出率和阳性预测值尚不清楚。
确定经验丰富的放射科医生对平均乳腺癌风险女性进行乳腺筛查超声的性能。
本研究获得机构审查委员会批准,并豁免了知情同意。对我们数据库的回顾性分析显示,1526名女性在单一健康筛查中心接受了乳腺普查超声检查,且数字乳腺X线摄影(MG)结果为阴性。对乳腺超声的乳腺影像报告和数据系统(BI-RADS)最终评估进行回顾性分析,参考标准定义为病理结果与12个月随访相结合。根据乳腺密度计算活检的癌症检出率和阳性预测值(PPV2)。
进行一次筛查超声检查的平均时间为15 - 20分钟。1526名女性中,1095名(71.8%)被归类为BI-RADS 1类或2类;340名(22.3%)被归类为3类;91名(6.0%)被归类为4类。在乳腺致密的女性中发现了5个恶性病变。总体癌症检出率为3.3,致密乳腺的癌症检出率为每1000次筛查5.1例(每1000次筛查中,不均匀致密乳腺为4.1例,极度致密乳腺为7.7例)。活检的PPV2为5.3%。
对平均风险且乳腺致密的女性进行放射科医生操作的筛查超声可检测出额外的乳腺X线摄影隐匿性乳腺癌。在筛查超声中,观察到BI-RADS 3类和4类病变的比例相对较高。